Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $797,426 (99.2% shares, 0.8% debt)

Holdings (17)

INGN INOGEN INC 54.7%
Value ($000) $435,998 Shares 3,549,320 Est. Cost $17.78 Unrealized +586.6%
ACCELERON PHARMA INC 7.6%
Value ($000) $60,759 Shares 1,553,937 Est. Cost $27.65 Unrealized
MENLO THERAPEUTICS INC 6.4%
Value ($000) $51,158 Shares 1,361,313 Est. Cost $37.58 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 6.4%
Value ($000) $50,969 Shares 4,420,516 Est. Cost $13.03 Unrealized -27.4%
UNUM THERAPEUTICS INC 4.0%
Value ($000) $31,669 Shares 665,181 Est. Cost $47.61 Unrealized
AKBA AKEBIA THERAPEUTICS INC 3.7%
Value ($000) $29,543 Shares 3,100,000 Est. Cost $12.34 Unrealized +13.4%
MERUS N V 3.3%
Value ($000) $26,135 Shares 1,410,417 Est. Cost $7.99 Unrealized
GKOS GLAUKOS CORP 2.2%
Value ($000) $17,424 Shares 565,165 Est. Cost $30.14 Unrealized +0.5%
DERMIRA INC 2.0%
Value ($000) $15,930 Shares 1,993,746 Est. Cost $30.14 Unrealized
VERONA PHARMA PLC 1.9%
Value ($000) $14,815 Shares 740,740 Est. Cost $11.66 Unrealized
NABRIVA THERAPEUTICS PLC 1.8%
Value ($000) $14,712 Shares 2,924,822 Est. Cost $10.02 Unrealized
CRSP CRISPR THERAPEUTICS AG 1.3%
Value ($000) $10,208 Shares 223,317 Est. Cost $18.69 Unrealized +120.8%
KIDS ORTHOPEDIATRICS INC 1.2%
Value ($000) $9,406 Shares 624,591 Est. Cost $18.57 Unrealized -4.6%
SEASPINE HLDGS CORP 1.2%
Value ($000) $9,333 Shares 920,380 Est. Cost $10.14 Unrealized
RA PHARMACEUTICALS INC 1.0%
Value ($000) $7,784 Shares 1,465,838 Est. Cost $15.19 Unrealized
WRIGHT MED GROUP N V 0.8%
Value ($000) $6,332 Shares 4,622,032 Est. Cost $1.25 Unrealized
INVUITY INC 0.7%
Value ($000) $5,251 Shares 1,363,848 Est. Cost $9.51 Unrealized